New study finds Smartwatch wristbands contain high levels of PFAS
Researchers found elevated level of PFAS in mostly fluorinated synthetic rubber wristbands.
Inside the country’s first official safe drug consumption site
An overdose prevention site in New York City continues its research-backed, lifesaving work.
How the Braiding Seeds Fellowship works to uproot racism in the food system
This Petersburgh, New York, organization fights racial injustice in the food system.
EPA bans cancer-causing chemicals used in dry cleaning and industry
EPA bans two cancer-causing chemicals, marking a critical step in protecting public health and the environment after decades of harm.
62% of Americans demand government-ensured healthcare as trust in for-profit system hits historic low
New Gallup poll shows record-high support for universal healthcare, with bipartisan frustration mounting over rising costs and systemic inequities.
EPA’s historic ban on toxic chemicals: A win for health, or a temporary victory?
The EPA bans two carcinogenic chemicals after decades of advocacy, but political and industrial challenges loom.
Glyphosate exposure linked to brain inflammation and neurodegenerative risks
A groundbreaking study links glyphosate exposure to long-term brain inflammation, raising concerns about its safety and potential role in neurodegenerative diseases.
Formaldehyde causes more cancer than any other toxic air pollutant. Little is being done...
Formaldehyde threatens everyone as it pollutes the air we all breathe and leaks from products long after they enter our homes. It is virtually everywhere.
‘A dose of nature’: Each time you visit a national park, you save the...
Our new research puts a dollar value on the health benefits of visits to national parks within reach of the city of Adelaide in South Australia.
143 million Americans may be exposed to toxic ‘forever chemicals’ in drinking water
Millions of Americans face exposure to toxic PFAS chemicals in drinking water, with new EPA data revealing the extent of contamination and fears of regulatory rollbacks under a Trump administration.









